Rechercher des projets européens

37 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 
Antimicrobial resistance (AMR) is a major global public health threat, and most troublesome is the rapid emergence and dissemination of multidrug resistant (MDR) Enterobacteriaceae, Acinetobacter species and Pseudomonas aeruginosa. There is an unmet medical need to prevent P. aeruginosa infection in critically ill patients and to develop new antibiotics for infections caused by Gram-negative bacte ...
Voir le projet

 44

 TERMINÉ 

Children’s Liver Tumour European Research Network (ChiLTERN)

Date du début: 1 janv. 2016, Date de fin: 31 déc. 2020,

Liver cancer in the paediatric population is rare with an incidence approximately 1-1.5 per million population. The commonest tumour seen in the childhood population is hepatoblastoma (HB), usually seen in young children and infants. Much rarer (about 10% of paediatric liver cancers) is hepatocellular carcinoma (HCC), usually seen in the teenage population and sometimes associated with underlying ...
Voir le projet

 21

 TERMINÉ 
Pharmacogenomics is the study of genetic variability affecting an individual’s response to a drug. Its use allows personalized medicine and reduction in ‘trial and error’ prescribing leading to more efficacious, safer and cost-effective drug therapy. The U-PGx consortium will investigate a pre-emptive genotyping approach (that is: multiple pharmacogenomic variants are collected prospectively and ...
Voir le projet

 16

 TERMINÉ 

Empowering Patients by Professional Stress Avoidance and Recovery Services (STARS)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,

Patient EmpowermentIndividualized tackling of unnecessary stress, in particular when related to healthcare procedures, promises to enhance the autonomy and quality of life of many people and yield a significant contribution to self-empowerment, thus relieving careers and related persons from personal assistance. Not at least, also a considerable economic relief (see Impact).This is the topic the S ...
Voir le projet

 13

 TERMINÉ 

REgenerative Stem cell therapy for STroke in Europe (RESSTORE)

Date du début: 1 sept. 2015, Date de fin: 31 août 2020,

Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and cognitive impairments, and secondary health problems affecting not only patients but also their families. Building on emerging preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of regenerative cell therapy to improve stroke ...
Voir le projet

 29

 TERMINÉ 

Combatting Bacterial Resistance in Europe - Carbapenem Resistance (COMBACTE-CARE)

Date du début: 1 mars 2015, Date de fin: 28 févr. 2020,

Multi-drug resistant Gram-negative bacteria (MDR-GNB): the ultimate challenge!Antibiotic resistance is a global public health concern recently elevated to the top three threats identified by the WHO, and subject of numerous national and international government activities. Although focused strategies have beneficially influenced infection rates due to methicillin resistant Staphylococcus aureus (M ...
Voir le projet

 23

 TERMINÉ 

Combatting Bacterial Resistance in Europe (COMBACTE-NET)

Date du début: 1 janv. 2013, Date de fin: 31 déc. 2019,

The emergence of Antibiotic-resistant bacteria (ARB) is a global problem, having recently been elevated to the top three threats identified by the World Health Organisation (WHO), and subject of numerous national and international government activities, including the Trans-Atlantic Task Force on Antimicrobial Resistance established by the US and EU presidencies. The estimated costs of ARB are aro ...
Voir le projet

 38

 TERMINÉ 
Ageing is the major risk factor for idiopathic PARKINSON'S DISEASE (PD), the first motor neurodegenerative disorder (in EU 1% in 65+; about 4% in 80+). The most recent conceptualizations of ageing and PD indicate that they share basic mechanisms, e.g. accumulation of senescent cells and propagation phenomena such as inflammaging mirrored in PD by neuro-inflammaging in brain that foster a prion-lik ...
Voir le projet

 10

 TERMINÉ 
The main objective of POWER2DM is to develop and validate a personalized self-management support system (SMSS) for T1 and T2 diabetes patients that combines and integrates (1) a decision support system (DSS) based on leading European predictive personalized models for diabetes interlinked with predictive computer models, (2) automated e-coaching functionalities based on Behavioural Change Theories ...
Voir le projet

 8

 TERMINÉ 

Support, Monitoring and Reminder Technology for Mild Dementia (SMART4MD)

Date du début: 1 avr. 2015, Date de fin: 31 mars 2019,

As Europe’s population is ageing, long-term care for elderly citizens will become an increasing cost for society. To manage this transition healthcare policies in the EU and individual Member States are heavily focussed on extending the independent life of the elderly, with the dual aim of increasing their quality of life and reducing the costs of care. Dementia affects more than 6% of people aged ...
Voir le projet

 12

 TERMINÉ 
RELIEF aims to link European health procurers in order to create the innovative and sustainable solutions that will improve chronic pain control/relieve through ITC self-management techniques.Chronic pain diseases is costing to healthcare systems annually over €300bn in Europe; 1.5%-3% of GDP (gross domestic product). Chronic pain entails a significant direct cost to healthcare systems. Consultati ...
Voir le projet

 6

 TERMINÉ 
We concur to the IMI on “Reclassification of SLE, connective tissue diseases and RA” call by presenting a proposal aimed at using the power of OMICs, and bioinformatics to identify new classifications for diseases known to share common pathophysiological mechanisms. Such knowledge has not been applied to individual patients, depriving them from potential benefits in terms of the use of new therape ...
Voir le projet

 30

 TERMINÉ 
The overall aim of LIQBIOPSENS project is the further development and validation in real settings of a novel diagnostic platform for the early and fast detection of ctDNA and their KRAS and BRAF mutations associated to colorectal cancer through blood samples. The main features of LIQBIOPSENS are: reliability (detection rates vary from 95–100 %), low-cost (40-50 € per sample analysis), sensitivity ...
Voir le projet

 7

 TERMINÉ 
Smoking is the largest avoidable cause of preventable morbidity worldwide. It causes most of the cases of lung cancer and chronic obstructive pulmonary disease (COPD) and contributes to the development of other lung diseases. The control of smoking is considered as a highly important intervention for the prevention of lung diseases. Tobacco consumption is highly influenced by socioeconomic factors ...
Voir le projet

 14

 TERMINÉ 
Ewing Sarcomas (ES) are fatal, rare bone cancers particularly affecting young people. About 60% of patients achieve long term survival with current treatment but there has been no improvement in this proportion for 25 years. Treatment is unsuccessful because chemotherapy fails to prevent the development of, or to effectively treat established, metastases. In addition, of the 600 new cases of ES o ...
Voir le projet

 21

 TERMINÉ 

European Clearing House for Open Robotics Development Plus Plus (ECHORD Plus Plus)

Date du début: 1 oct. 2013, Date de fin: 30 sept. 2018,

Description ECHORD++ will create new opportunities for European robotics researchers to work directly with SME/start-ups and new users/customers to create innovative products. ECHORD++ will continue ECHORD’s two pillars, “experiments” and “structured dialogue”, taking advantage of experience and investment in the infrastructure. In addition, ...
Voir le projet

 68

 TERMINÉ 
"Background: A significant proportion of pre-diabetics, show macro and micro vascular complications associated with hyperglycaemia. Although many trials have demonstrated the efficacy of lifestyle and pharmaceutical interventions in diabetes prevention, no trial has evaluated the extent to which mid- and long-term complications can be prevented by early interventions on hyperglycaemia.Aims: To ass ...
Voir le projet

 37

 TERMINÉ 
HEARTEN will design, develop and validate an ICT co-operative environment that will enable the HF patients to achieve sustainable behavior change regarding their adherence and compliance, and the ecosystem actors to be engaged and improve the patients’ HF management. HEARTEN targets all actors related to the management of patients suffering from HF, including healthcare professionals, caregivers ( ...
Voir le projet

 14

 TERMINÉ 

European Multicentre Tics in Children Studies (EMTICS)

Date du début: 1 déc. 2011, Date de fin: 31 mai 2017,

This project will undertake pre-clinical and cohort studies that address susceptibility factors for paediatric and adolescent tic disorders, with a particular focus on comorbid obsessive-compulsive symptomatology, from clinical, epidemiological, genetic, microbiological and immunological angles. EMTICS aims to elucidate the complex aetiology of the onset and clinical course of chronic tic disorder ...
Voir le projet

 33

 TERMINÉ 
The FAST project aims at the development of safe and effective treatment of food allergies. It targets persistent and severe allergy to fish and fruit. Besides persistence and severity, this choice is based on prevalence and the importance of these foods for a healthy diet. Classical allergen-specific immunotherapy (SIT) for treatment of food allergy using subcutaneous injections with food extract ...
Voir le projet

 19

 TERMINÉ 
Large scale genomics projects exploiting high throughput leading technology have produced and continue to produce massive data sets with exponential growing rates. So far, only a small part of this data can be abstracted, managed and processed, giving an incomplete understanding of the biological process being observed. The lack of processing power is a bottle neck in acquiring results. Comparativ ...
Voir le projet

 6

 TERMINÉ 
Public Procurement of Innovation (PPI) is a crucial challenge for public bodies to be implemented during next years. The “usual” way of purchasing goods is based solely on the price of the product. Life cycle costing, supply chain analysis or group purchase are rarely used, which means missing some opportunities to get innovative products that would give purchasers competitive advantage. Therefore ...
Voir le projet

 8

 TERMINÉ 
Sarcomas are rare malignant tumors, with an overall incidence of 6/105/year. Bone and soft tissue connective tissue tumours encompass more than 50 different rare histotypes and more than 150 different molecular subtypes. The incidence of individual rare sarcomas subtypes is often less than 0.5/105/year. Given sarcoma rarity as a group, but even more as individual entities, few prospective clinical ...
Voir le projet

 22

 TERMINÉ 
Background. Ventilator-associated pneumonia (VAP) is one of the most common and severe hospital-adquired infections, and multidrugresistant gram-negative bacilli (MDR-GNB) constitute the main etiology in many countries. Inappropriate empiric antimicrobial treatment is associated with increased mortality. In this context, the empirical treatment of choice for VAP is unknown. Colistin, and “old” dru ...
Voir le projet

 11

 TERMINÉ 

PAtients Leading and mANaging their healThcare through EHealth (PALANTE)

Date du début: 1 févr. 2012, Date de fin: 31 juil. 2015,

Patient empowerment is considered a potential tool to reduce healthcare costs and improve efficiency of the health systems, reinforcing healthcare quality. Patient empowerment has become an element of high priority in the EU health strategy, supported by national and regional health authorities.Building on already existing e-health platforms and services in the participating regions, the PALANTE p ...
Voir le projet

 21

 TERMINÉ 
Hospitals are known to be large energy consumers and in most European countries the high proportion of ageing building stocks makes hospitals amongst the least energy efficient public buildings. Nowadays there is a growing urgency to achieve real energy savings from existing building stocks and to build more sustainable new hospitals.The GREEN@Hospital project aims at integrating the latest ICT so ...
Voir le projet

 11

 TERMINÉ 

Rehabilitative Wayout In Responsive home Environments (REWIRE)

Date du début: 1 oct. 2011, Date de fin: 31 déc. 2014,

Description The REWIRE project develops, integrates and field tests an innovative rehabilitation platform based on virtual reality. The platform allows patients, discharged by the hospital, to continue their intensive rehabilitation at home under remote monitoring by the hospital itself. The patient sees on the display himself or an avatar m ...
Voir le projet

 13

 TERMINÉ 
Description GIRAFF+ develops a system for early detection and adaptive support to people's changing needs related to ageing. The Giraff+-system consists of a network of home sensors that measure e.g. blood pressure and temperature, or detect e.g. whether somebody occupies a chair, falls down or moves inside a room. The data from these sensor ...
Voir le projet

 12

 TERMINÉ 
Description SOS project becomes Smart Open Services for European Patients (epSOS) to better reflect the focus on patient needs.Patient summaries and ePrescriptionsPatient summaries and electronic prescriptions (ePrescriptions) are two key services that enable high quality medical care. Such health records provide health professionals with ...
Voir le projet

 45

 TERMINÉ 

Fatty liver: Inhibition of Progression (FLIP)

Date du début: 1 janv. 2010, Date de fin: 30 juin 2013,

"Non-alcoholic fatty liver disease (NAFLD) has become one of the top concerns for the practising hepatogastroenterologist due to the obesity epidemic and its potential to progress to advanced liver disease which significantly impacts on overall and liver-related mortality. The aim of the FLIP (Fatty Liver: Inhibition of Progression) project is to understand and prevent the progression of liver dis ...
Voir le projet

 17

 TERMINÉ 
The goal of this collaboration is to develop a roadmap for future European research in CAM that is appropriate for the health care needs of EU citizens, and acceptable to the EU parliament as well as their national research funders and healthcare providers. We will enable meaningful reliable comparative research and communication within Europe and create a sustainable structure and policy. CAMbrel ...
Voir le projet

 17

 TERMINÉ 
OBJETIVOS: Promover u desarrollar una red conjunta de infraestructuras logísticas de cooperación sanitaria en el ámbito de la atención materno-infantil. ACCIONES: " Impulsar la atención humanizada al parto normal. Dotación de equipamiento para posibilitar diferentes modalidades de parto. / " Garantizar las buenas prácticas en base a la evidencia científica en la atención sanitaria de madres e hijo ...
Voir le projet

 2

 TERMINÉ 
OBJETIVOS: Objetivo general: Aumentar la seguridad de la atención sanitaria a la población infantil en situación crítica ACCIONES: " Adecuación de las infraestructuras actuales de las Unidades de Cuidados Intensivos Pediátricos y Neonatales." Dotación de las últimas tecnologías para una óptima seguridad en la atención para evitar los efectos indeseables que se producen el proceso de atención." Ela ...
Voir le projet

 2

 TERMINÉ 
"Direct vaccination cannot prevent diseases that affect neonates in the first days of life. Group B Streptococcus (GBS) is the major cause of neonatal septicemia and meningitis affecting up to one in every thousand live births. Over 80% of cases occur in the first 7 days after birth and the remaining 20% of disease occurs between 8-90 days after birth. Studies carried out in the USA indicate that ...
Voir le projet

 10

 TERMINÉ 
Impulsar la sistematización y adecuación del procedimiento de correcta identificación de pacientes en toda la cadena transfusional en los hospitales y los centros de transfusión. Implantar prácticas transfusionales seguras en los centros sanitarios. ...
Voir le projet

 1

 TERMINÉ 
OBJETIVO: Potenciar la protección del medio mediante la implantación de criterios comunes de Gestión ambiental en centros sanitarios de la región Algarve-HuelvaACCIONES: Gestión eficacia energética. Concienciación e infraestructuras; Ahorro de recursos naturales; Eficacia y reducción en la gestión de los residuos peligrosos y sustitución de materiales peligrosos. ...
Voir le projet

 2

 TERMINÉ 
OBJETIVO: Establecer líneas de cooperación sanitaria en diversas áreas de actividad y de la que se beneficien tanto los ciudadanos portugueses como andaluces que habitan a ambos lados de la frontera. Creación de un observatorio de salud conjunto entre Andalucía y el Algarve y estructuras sanitarias de uso común, así como sistemas de información comunes para el registro de las actividadesACCIONES: ...
Voir le projet

 2